PRISModegib: the use of the PRISM test to assess the health‐related quality of life of patients with locally advanced basal cell carcinoma undergoing Hedgehog pathway inhibitor therapy. (1st August 2019) - Gualdi, G.; Moro, R.; Regina, V.; Caravello, S.; Monari, P.; Calzavara‐Pinton, P.G.